| Original language | English |
|---|---|
| Number of pages | 1 |
| Journal | Journal of Clinical Oncology |
| Volume | 40 |
| Issue number | 16 |
| Publication status | Published - 1 Jun 2022 |
A phase II study to evaluate the safety and efficacy of IMM-101 in combination with checkpoint inhibitors in patients with advanced melanoma: Final results of the IMM101-015 trial.
A Fusi, A Gupta, P Lorigan, PL Smith, M Bowles
Research output: Contribution to journal › Meeting Abstract › peer-review
